Sanofi SA (NAS:SNY)
$ 48.29 -0.1 (-0.21%) Market Cap: 121.07 Bil Enterprise Value: 139.04 Bil PE Ratio: 26.55 PB Ratio: 1.57 GF Score: 84/100

Sanofi SA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 02:30PM GMT
Release Date Price: $51.54 (+1.36%)
Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Good morning, good afternoon, and good evening, everybody. And thank you for joining us. My name is Keyur Parekh, and I cover Sanofi for Goldman Sachs.

Bill, thank you so much for joining us. It's my pleasure to welcome Bill Sibold, who is Executive Vice President, Head of Sanofi Genzyme and also a member of the Executive Committee at Sanofi. Bill, once again, thank you so much for your time, and thank you for joining us.

Before we move to kind of Q&A session, Bill, I don't know if you want to make a few introductory comments kind of on some of the recent kind of data sets you guys have presented, what are you seeing in the business? And then we can take it to Q&A from that.

William J. Sibold
Sanofi - EVP of Sanofi Genzyme

Sure. That's great. Well thank you, Keyur, and thank you, everyone, for joining. It's a real pleasure to be here, though I certainly wish that we were all live in California.

We've been making great progress in our Play to Win

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot